Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY-NC-ND 4.0Ca

Screening for prostate cancer

Related

  1. The PROSA and cons of prostate cancer screening.
    Rory L Cochran, Mukesh G Harisinghani
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  2. Prostate‐specific antigen‐based screening for prostate cancer: A systematic review to inform an American Cancer Society guideline
    Jessica C. Griffin, Rita L. Shiau, Clarissa A. B. Troutman +5
    CancerPeer-reviewedCC BY-NC-ND 4.0Full text2 citedGeneral medicinePMC
  3. Biomarker use in the prostate cancer screening pathway: Maps of the evidence
    Rita L. Shiau, Jessica C. Griffin, Clarissa A. B. Troutman +2
    CancerPeer-reviewedCC BY-NC-ND 4.0Full text2 citedGeneral medicinePMC
  4. Inverse association between macronutrient quality index and renal cancer incidence: results from the prostate, lung, colorectal, and ovarian cancer screening trial
    Lulu Zhou, Shouguang Xie, Yuxiang Luo +3
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefDOAJ
  5. Estimated lifetime harms and benefits of continuing biennial prostate cancer screening in older men by comorbidity group
    Roman Gulati, Krithika Suresh, Sarah P. Psutka +5
    CancerPeer-reviewedCC BY-NC 4.0Full text1 citedEpidemiology & public healthPMC
BibTeX
@article{anon2026screening,
  title = {{Screening for prostate cancer}},
  journal = {Ca},
  year = {2026},
  month = nov,
  doi = {10.3322/caac.70114},
  url = {https://doi.org/10.3322/caac.70114},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Screening for prostate cancer
PY  - 2026
DA  - 2026/11/12
JO  - Ca
DO  - 10.3322/caac.70114
UR  - https://doi.org/10.3322/caac.70114
SN  - 0007-9235
SN  - 1542-4863
ER  -